Wells Fargo downgraded Exelixis (EXEL) to Equal Weight from Overweight with an unchanged price target of $36.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Exelixis announces final five-year follow-up results from CheckMate -9ER
- Exelixis Hold Rating Maintained Amidst Stable Financials and Awaited Trial Data
- Exelixis Earnings Call: Positive Growth and Ambitious Goals
- Exelixis price target raised to $38 from $34 at TD Cowen
- Exelixis price target raised to $36 from $30 at Stifel